Abstract:Objective To explore the clinical effect of Tangbikang in the treatment of qi deficiency and blood stasis diabetic peripheral neuropathy.Methods A total of 80 patients with diabetic peripheral neuropathy treated in our hospital from October 2016 to March 2017 were selected as the subjects,and divided into two groups by random number table method.In the control group,patients were treated with the basic treatment combined with Mecobalanin Tablets,and in the observation group,patients were treated with Tangbikang based on the treatment of the control group.Both groups were given one course of treatment for 8 weeks.The clinical efficacy,TCSS scores,changes of nerve conduction velocity,and changes of hemorheology indexes between the two groups were compared.Results The total effective rate in the observation group was 87.5%,which was higher than in the control group(67.5%),the difference was statistically significant(P<0.05).After treatment,the TCSS scores of the two groups were lower than that before treatment,and the TCSS scores of the observation group was lower than that of the control group,the difference was statistically significant(P<0.05).After treatment,MNCV and SNCV of median nerve and peroneal nerve in the two groups were higher than those before treatment,and MNCV and SNCV in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).Hemorheological indexes in the observation group after treatment were better than those before treatment and the control group,and the differences were statistically significant(P<0.05).Conclusion The efficacy of Self-designed Tangbikang is benefiting qi for activating blood circulation and dispersing blood stasis and dredging collateral,it can effectively treat the diabetic peripheral neuropathy,has the guiding significance to the clinic treatment,and it deserves the clinical promotion.